Resminostat: Opening the door to epigenetic treatments for liver cancer. (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep.27853
PubMed Identifier: 25891162
Publication URI: http://europepmc.org/abstract/MED/25891162
Type: Journal Article/Review
Volume: 63
Parent Publication: Hepatology (Baltimore, Md.)
Issue: 2
ISSN: 0270-9139